发明名称 GLUCOSE INDUCIBLE INSULIN EXPRESSION AND METHODS OF TREATING DIABETES
摘要 A glucose response promoter is provided to induce restoration of physiological properties of insulin-producing beta cell, and control glucose homeostasis in a patient suffering from diabetes by inducing insulin expression as increase of glucose concentration, so that the promoter is useful for treatment of diabetes. A glucose response promoter specific to the isolated tissue contains polymerase binding domain 3' comprising a liver pyruvate kinase(LPK) promoter to at least one tripartite transcription factor binding cis element having a hepatocyte nuclear factor-1(HNF-1) element, CAAT/enhancer binding protein(C/EBP) response element and glucose-response element(GRE). A host cell comprises the glucose responsive promoter. The diabetes are prevented and treated by administering an effective amount of a virus particle having a vector containing the glucose responsive promoter comprising a polymerase binding domain 3' to at least one tripartite transcription factor binding cis element having the hepatocyte nuclear factor-1 element, a C AAT/enhancer binding protein response element and the glucose-response element which are operationally linked to a nucleic acid encoding insulin of which expression is tissue specific and glucose responsive to a patient suffering from diabetes. Further, the HNF-1 element comprises 25 to 30 nucleotide, and the GRE comprises 45 to 50 nucleotide.
申请公布号 KR20080036015(A) 申请公布日期 2008.04.24
申请号 KR20077030350 申请日期 2007.12.26
申请人 BIOTECH INSTITUTE FOR INTERNATIONAL INNOVATION, INC. 发明人 YOON, JI WON
分类号 C12N15/10;A61K31/70;C12N15/09 主分类号 C12N15/10
代理机构 代理人
主权项
地址